-
Long COVID exhibits clinically distinct phenotypes at 3–6 months post-SARSCoV-2 infection: results from the P4O2 consortium
Blankestijn, J. M., Abdel-Aziz, M. I., Baalbaki, N., Bazdar, S., Beekers, I., Beijers, R. J. H. C. G., Bloemsma, L. D., Cornelissen, M. E. B., Gach, D., Houweling, L., Holverda, S., Jacobs, J. J. L., Jonker, R., van der Lee, I., Linders, P. M. A., Mohamed Hoesein, F. A. A., Noij, L. C. E., Nossent, E. J., van de Pol, M. A., Schaminee, D. W., & 8 others, 24 Apr 2024, In: BMJ Open Respiratory Research. 11, 1, e001907.Research output: Contribution to journal › Article › Academic › peer-review
-
Precision Medicine for More Oxygen (P4O2)—Study Design and First Results of the Long COVID-19 Extension
on behalf of the P4O2 Consortium, 1 Jul 2023, In: Journal of Personalized Medicine. 13, 7, 1060.Research output: Contribution to journal › Article › Academic › peer-review
-
A Systematic Review of Chest Imaging Findings in Long COVID Patients
on behalf of the P4O2 Consortium, 1 Feb 2023, In: Journal of Personalized Medicine. 13, 2, 282.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications
